Clinical Trials Directory

Trials / Completed

CompletedNCT03911427

Oat and Cholesterol

Impact of Oat Product on LDL Cholesterol in Healthy Men and Women With Elevated LDL-cholesterol

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
207 (actual)
Sponsor
PepsiCo Global R&D · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The primary objective is to assess the effect of an oat ingredient provided over 4 weeks on serum LDL cholesterol in men and women with elevated LDL-cholesterol compared to a placebo. Secondary endpoints are fasting serum total- and HDL-cholesterol, non-HDL-cholesterol, triglycerides, glucose, insulin, glycated albumin, HOMA-IR and Framingham risk score

Conditions

Interventions

TypeNameDescription
OTHERActive oat beveragePowder packaged in sachets, mixed with water and consumed 3 times per day for 1 month
OTHERControl rice beveragePowder packaged in sachets, mixed with water and consumed 3 times per day for 1 month

Timeline

Start date
2019-04-10
Primary completion
2020-02-20
Completion
2020-02-28
First posted
2019-04-11
Last updated
2020-03-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03911427. Inclusion in this directory is not an endorsement.